\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ pending\ \(213\)\
\-\ bilateral\\ enhancing\\ masses\\ within\\ the\\ carotid\\ space\\ \\(sheath\\)\\ on\\ both\\ sides\\.\\ \\ masses\\ have\\ flow\\ voids\\ and\\ splay\\ open\\ the\\ proximal\\ internal\\ from\\ external\\ carotid\\ arteries\\ at\\ the\\ carotid\\ bifurcation\\.\ \(0\)\
\-\ bilateral\\ carotid\\ body\\ tumors\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ lymphadenopathy\ \(0\)\
\-\ \\â\\€\\¢\\ vagal\\ nerve\\ schwannomas\\ \ \(0\)\
\-\ \\â\\€\\¢\\ thyroid\\ cancer\\ adenopathy\ \(0\)\
\-\ \\â\\€\\¢\\ bilateral\\ paragangliomas\ \(0\)\
\-\ 38\\ year\\ old\\ male\\ with\\ history\\ of\\ minor\\ trauma\\ 1\\ year\\ prior\\ to\\ presentation\\.\\ \\ mri\\ cervical\\ spine\\ was\\ done\\ at\\ outside\\ hospital\\ because\\ of\\ complaints\\ of\\ persistent\\ neck\\ pain\\.\\ \\ abnormality\\ seen\\ on\\ outside\\ mri\\;\\ and\\,\\ a\\ followup\\ ct\\ scan\\ was\\ recommended\\.\ \(0\)\
\-\ the\\ presences\\ of\\ bilateral\\ paragangliomas\\ suggests\\ a\\ genetic\\ predisposition\\:\ \(0\)\
\-\ \\â\\€\\¢\\ vhl\\ \\-\\ von\\ hippel\\-lindau\\ \\(autosomal\\ dominant\\ \\-\\ ad\\)\ \(0\)\
\-\ \\â\\€\\¢\\ men2a\\ \\/\\ men2b\\ \\-\\ multiple\\ endocrine\\ neoplasia\\ syndrome\\ \\(ad\\)\ \(0\)\
\-\ \\â\\€\\¢\\ neurofibromatosis\\ type\\ 1\\ \\-\\ nf1\\,\\ von\\ recklinghausen\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ familial\\ paraganglioma\\ syndrome\\ \\ \\(succinate\\ dehydrogenase\\ mutation\\)\\ http\\:\\/\\/www\\.ncbi\\.nlm\\.nih\\.gov\\/books\\/nbk1548\\/\\?report\\=printable\ \(0\)\
\-\ http\\:\\/\\/radiographics\\.rsna\\.org\\/content\\/19\\/6\\/1605\\.full\ \(1\)\
\-\ http\\:\\/\\/www\\.eimjm\\.com\\/vol5\\-no1\\/vol5\\-no1\\-c8\\.htm\ \(0\)\
\-\ familial\\ paragangliomas\\:\\ http\\:\\/\\/endocrinediseases\\.org\\/adrenal\\/paraganglioma\\_genetic\\.shtml\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ paragangliomas\\:\\ 0\\.12468211162257592\ \(0\)\
\-\ carotid\\:\\ 0\\.09069613733155413\ \(0\)\
\-\ http\\:\\ 0\\.07658671237823138\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.07417819415838522\ \(0\)\
\-\ ad\\:\\ 0\\.06887320888062139\ \(0\)\
\-\ von\\:\\ 0\\.06368675999386215\ \(0\)\
\-\ familial\\:\\ 0\\.06191715367467915\ \(0\)\
\-\ presences\\:\\ 0\\.052162830911044365\ \(0\)\
\-\ men2a\\:\\ 0\\.052162830911044365\ \(0\)\
\-\ men2b\\:\\ 0\\.052162830911044365\ \(0\)\
\-\ \\/\\/www\\.ncbi\\.nlm\\.nih\\.gov\\/books\\/nbk1548\\/\\:\\ 0\\.052162830911044365\ \(0\)\
\-\ report\\=printable\\:\\ 0\\.052162830911044365\ \(0\)\
\-\ \\/\\/radiographics\\.rsna\\.org\\/content\\/19\\/6\\/1605\\.full\\:\\ 0\\.052162830911044365\ \(0\)\
\-\ \\/\\/www\\.eimjm\\.com\\/vol5\\-no1\\/vol5\\-no1\\-c8\\.htm\\:\\ 0\\.052162830911044365\ \(0\)\
\-\ \\/\\/endocrinediseases\\.org\\/adrenal\\/paraganglioma\\_genetic\\.shtml\\:\\ 0\\.052162830911044365\ \(0\)\
\-\ bilateral\\:\\ 0\\.04908444329738329\ \(0\)\
\-\ succinate\\:\\ 0\\.048061368304180785\ \(0\)\
\-\ splay\\:\\ 0\\.045662166481055554\ \(0\)\
\-\ \\-\\:\\ 0\\.04335451973274233\ \(0\)\
\-\ dehydrogenase\\:\\ 0\\.042639529654037854\ \(0\)\
\-\ outside\\:\\ 0\\.0424190509717386\ \(0\)\
\-\ vhl\\:\\ 0\\.041560703874191966\ \(0\)\
\-\ recklinghausen\\:\\ 0\\.041560703874191966\ \(0\)\
\-\ \\:\\:\\ 0\\.04012809997599994\ \(0\)\
\-\ vagal\\:\\ 0\\.039858443090453624\ \(0\)\
\-\ predisposition\\:\\ 0\\.038538067047174274\ \(0\)\
\-\ schwannomas\\:\\ 0\\.03575698048359004\ \(0\)\
\-\ nf1\\:\\ 0\\.035398254910711725\ \(0\)\
\-\ neoplasia\\:\\ 0\\.035060039444203155\ \(0\)\
\-\ hippel\\-lindau\\:\\ 0\\.03443660444031069\ \(0\)\
\-\ masses\\:\\ 0\\.03418452542007204\ \(0\)\
\-\ mutation\\:\\ 0\\.03223800351467469\ \(0\)\
\-\ sides\\:\\ 0\\.031473437056213124\ \(0\)\
\-\ endocrine\\:\\ 0\\.031296792303848145\ \(0\)\
\-\ paraganglioma\\:\\ 0\\.031296792303848145\ \(0\)\
\-\ bifurcation\\:\\ 0\\.030796452729717594\ \(0\)\
\-\ autosomal\\:\\ 0\\.02925631605360123\ \(0\)\
\-\ syndrome\\:\\ 0\\.02892197132230345\ \(0\)\
\-\ voids\\:\\ 0\\.02889759048072291\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.02793594001032188\ \(0\)\
\-\ sheath\\:\\ 0\\.027838133489900514\ \(0\)\
\-\ genetic\\:\\ 0\\.02764724081405305\ \(0\)\
\-\ 38\\:\\ 0\\.026939873058728893\ \(0\)\
\-\ minor\\:\\ 0\\.025944980030314698\ \(0\)\
\-\ dominant\\:\\ 0\\.025805746317828344\ \(0\)\
\-\ suggests\\:\\ 0\\.025279429832523636\ \(0\)\
\-\ \\/\\:\\ 0\\.02497277262622431\ \(0\)\
\-\ followup\\:\\ 0\\.02413798802113611\ \(0\)\
\-\ 1\\:\\ 0\\.02406303394035156\ \(0\)\
\-\ mri\\:\\ 0\\.023234033785971834\ \(0\)\
\-\ adenopathy\\:\\ 0\\.022514101360178947\ \(0\)\
\-\ open\\:\\ 0\\.022474784539358424\ \(0\)\
\-\ complaints\\:\\ 0\\.021950135799206613\ \(0\)\
\-\ pending\\:\\ 0\\.021878843855323925\ \(0\)\
\-\ external\\:\\ 0\\.0215013897850557\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.0215013897850557\ \(0\)\
\-\ done\\:\\ 0\\.02096165009114054\ \(0\)\
\-\ recommended\\:\\ 0\\.02096165009114054\ \(0\)\
\-\ arteries\\:\\ 0\\.02093138322328983\ \(0\)\
\-\ thyroid\\:\\ 0\\.02072374227766101\ \(0\)\
\-\ persistent\\:\\ 0\\.02016773167163538\ \(0\)\
\-\ \\?\\:\\ 0\\.019733014796594714\ \(0\)\
\-\ hospital\\:\\ 0\\.01903607375720783\ \(0\)\
\-\ tumors\\:\\ 0\\.0189924044832574\ \(0\)\
\-\ abnormality\\:\\ 0\\.01865418901674883\ \(0\)\
\-\ cervical\\:\\ 0\\.018373321932494843\ \(0\)\
\-\ nerve\\:\\ 0\\.018218616133060982\ \(0\)\
\-\ because\\:\\ 0\\.017689457494591998\ \(0\)\
\-\ presentation\\:\\ 0\\.01741657180172238\ \(0\)\
\-\ \\(\\:\\ 0\\.017097318964351727\ \(0\)\
\-\ type\\:\\ 0\\.01704511377720065\ \(0\)\
\-\ available\\:\\ 0\\.01699833756709939\ \(0\)\
\-\ internal\\:\\ 0\\.01695192823301048\ \(0\)\
\-\ \\)\\:\\ 0\\.016888466085522014\ \(0\)\
\-\ space\\:\\ 0\\.016725189390986002\ \(0\)\
\-\ flow\\:\\ 0\\.016710377969577018\ \(0\)\
\-\ spine\\:\\ 0\\.016651500272220992\ \(0\)\
\-\ cancer\\:\\ 0\\.016622279670797428\ \(0\)\
\-\ body\\:\\ 0\\.01642167877330819\ \(0\)\
\-\ enhancing\\:\\ 0\\.015857713212335853\ \(0\)\
\-\ proximal\\:\\ 0\\.015180728885840326\ \(0\)\
\-\ neck\\:\\ 0\\.014847592526736583\ \(0\)\
\-\ scan\\:\\ 0\\.014155452428597505\ \(0\)\
\-\ trauma\\:\\ 0\\.013828454329928574\ \(0\)\
\-\ at\\:\\ 0\\.013701339086764887\ \(0\)\
\-\ prior\\:\\ 0\\.012982915811848305\ \(0\)\
\-\ both\\:\\ 0\\.01291242598039125\ \(0\)\
\-\ metastatic\\:\\ 0\\.012728458009562665\ \(0\)\
\-\ \\;\\:\\ 0\\.011984740760074518\ \(0\)\
\-\ was\\:\\ 0\\.0116955919788602\ \(0\)\
\-\ year\\:\\ 0\\.011314855257667629\ \(0\)\
\-\ have\\:\\ 0\\.010949337741805277\ \(0\)\
\-\ multiple\\:\\ 0\\.010649739665557803\ \(0\)\
\-\ seen\\:\\ 0\\.009991879379098758\ \(0\)\
\-\ within\\:\\ 0\\.009645747978615867\ \(0\)\
\-\ male\\:\\ 0\\.009143228034837119\ \(0\)\
\-\ on\\:\\ 0\\.008566757542786132\ \(0\)\
\-\ disease\\:\\ 0\\.008264719178791149\ \(0\)\
\-\ from\\:\\ 0\\.007493702444699481\ \(0\)\
\-\ not\\:\\ 0\\.007306619359419736\ \(0\)\
\-\ ct\\:\\ 0\\.007072802682793153\ \(0\)\
\-\ history\\:\\ 0\\.006983517974598127\ \(0\)\
\-\ pain\\:\\ 0\\.006175196257578312\ \(0\)\
\-\ old\\:\\ 0\\.005177127792084347\ \(0\)\
\-\ a\\:\\ 0\\.004693488778918358\ \(0\)\
\-\ the\\:\\ 0\\.003272172419020729\ \(0\)\
\-\ \\,\\:\\ 0\\.0032036694144057676\ \(0\)\
\-\ of\\:\\ 0\\.0027574864094198443\ \(0\)\
\-\ to\\:\\ 0\\.0025270302274732915\ \(0\)\
\-\ and\\:\\ 0\\.0021302840915055437\ \(0\)\
\-\ \\.\\:\\ 0\\.0010502821330575821\ \(0\)\
\-\ with\\:\\ 0\\.0006923324028987558\ \(0\)\
